Bnf for Children 2014-2015
Series: British National Formulary for Children; British National Formulary for Children
Publisher: Pharmaceutical Press
Published: 2014
Place of publication: London
Language: eng
Number of pages: 896
ISBN-13: 9780857111630; 9780857111364
Subjects: Pediatric pharmacology; Handbooks, manuals; Drugs; Administration; MEDICAL; Pharmacology
Description: Essential practical information for all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children.
Table of contents: title: Cover; Contents; Preface; Acknowledgements; BNF Staff; Paediatric FormularyCommittee 2013-2014; Dental Advisory Group 2013-2014; Nurse Prescribers' Advisory Group 2013-2014; How BNF for Children is constructed; How to use BNF for Children; Changes; General guidance; Prescription writing; Supply of medicines; Emergency supply of medicines; Prescribing Controlled Drugs; Adverse reactions to drugs; Prescribing in hepatic impairment; Prescribing in renal impairment; Prescribing in pregnancy; Prescribing in breast-feeding; Prescribing in palliative care; Prescribing in dental practice.; title: Drugs and sportEmergency treatment ofpoisoning; 1 Gastro-intestinal system; 1.1 Dyspepsia and gastrooesophagealrefluxdisease; 1.2 Antispasmodics and other drugs altering gut motility; 1.3 Antisecretory drugs and mucosal protectants; 1.4 Acute diarrhoea; 1.5 Chronic bowel disorders; 1.6 Laxatives; 1.7 Local preparations for anal and rectal disorders; 1.8 Stoma and enteralfeeding tubes; 1.9 Drugs affecting intestinal secretions; 2 Cardiovascular system; 2.1 Positive inotropic drugs; 2.2 Diuretics; 2.3 Anti-arrhythmic drugs; 2.4 Beta-adrenoceptorblocking drugs; 2.5 Hypertension.; title: 2.6 Nitrates, calcium-channel blockers, and otherantianginal drugs2.7 Sympathomimetics; 2.8 Anticoagulants andprotamine; 2.9 Antiplatelet drugs; 2.10 Myocardial infarction andfibrinolysis; 2.11 Antifibrinolytic drugs and haemostatics; 2.12 Lipid-regulating drugs; 2.13 Local sclerosants; 2.14 Drugs affecting theductus arteriosus; 3 Respiratory system; 3.1 Bronchodilators; 3.2 Corticosteroids; 3.3 Cromoglicate and related therapy and leukotrienereceptor antagonists; 3.4 Antihistamines, immunotherapy, and allergic emergencies; 3.5 Respiratory stimulants and pulmonarysurfactants; 3.6 Oxygen.; title: 3.7 Mucolytics3.8 Aromatic inhalations; 3.9 Cough preparations; 3.10 Systemic nasaldecongestants; 3.11 Antifibrotics; 4 Central nervous system; 4.1 Hypnotics andanxiolytics; 4.2 Drugs used in psychosesand related disorders; 4.3 Antidepressant drugs; 4.4 CNS stimulants and other drugs for attention deficit hyperactivitydisorder; 4.5 Drugs used in thetreatment of obesity; 4.6 Drugs used in nausea and vertigo; 4.7 Analgesics; 4.8 Antiepileptics; 4.9 Drugs used in dystonias and related disorders; 4.10 Drugs used in substance dependence; 4.11 Drugs for dementia; 5 Infections.; title: 5.1 Antibacterial drugs5.2 Antifungal drugs; 5.3 Antiviral drugs; 5.4 Antiprotozoal drugs; 5.5 Anthelmintics; 6 Endocrine system; 6.1 Drugs used in diabetes; 6.2 Thyroid and antithyroid drugs; 6.3 Corticosteroids; 6.4 Sex hormones; 6.5 Hypothalamic and pituitary hormones; 6.6 Drugs affecting bone metabolism; 6.7 Other endocrine drugs; 7 Obstetrics, gynaecology, and urinary-tract disorders; 7.1 Drugs used in obstetrics; 7.2 Treatment of vaginal and vulval conditions; 7.3 Contraceptives; 7.4 Drugs for genito-urinary disorders; 8 Malignant disease and immunosuppression; 8.1 Cytotoxic drugs.